Pfizer Inc. (NYSE: PFE) shares closed higher on Wednesday.
The company is reportedly discontinuing its pharmaceutical sciences small molecule (PSSM) operations at Sandwich in Kent, UK to streamline operations and enhance efficiency.
On Nov. 17, Astellas Pharma and Pfizer announced the FDA approval of a supplemental marketing application for Xtandi (Enzalutamide) for nonmetastatic castration-sensitive prostate cancer with biochemical recurrence at high risk for metastasis.
With the recent buzz around Pfizer, some investors may be eyeing potential gains from the company’s dividends. As of now, Pfizer has a dividend yield of 5.45%, which is a quarterly dividend amount of 41 cents a share ($1.64 a year).
To figure out how to earn $500 monthly from Pfizer dividends, we start with the yearly ...